TY  - BOOK
AU  - Ysebaert,Loïc
TI  - Main clinical studies of Bruton’s tyrosine kinase inhibitors (BTKis)
PY  - 2024///.
							
N1  - 86
N2  - Quality of life evaluation is crucial in therapeutic trials in hematology, but is not yet recognized as the only true patient-centered primary endpoint. For chronic lymphocytic leukemia patients, how can we move beyond focusing solely on progression-free survival to truly consider overall survival with good quality of life?
UR  - https://shs.cairn.info/journal-hematologie-2024-Supp1-page-44?lang=en
ER  -